AbbVie Inc (ABBV) financials
AbbVie revenue and earnings by year
AbbVie's revenue was $61.2 billion in the fiscal year to December 31, 2025, up 8.6% from the year before. Net income was $4.23 billion, 6.9% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 10.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 61.2 | 56.3 | 54.3 | 58.1 | 56.2 | 45.8 | 33.3 | 32.8 | 28.2 | 25.6 |
| Revenue growth | 8.6% | 3.7% | -6.4% | 3.3% | 22.7% | 37.7% | 1.6% | 16.1% | 10.1% | — |
| Gross profit | 43.0 | 39.4 | 33.9 | 40.6 | 38.8 | 30.4 | 25.8 | 25.0 | 21.2 | 19.8 |
| Gross margin | 70.2% | 70.0% | 62.4% | 70.0% | 69.0% | 66.4% | 77.6% | 76.4% | 75.0% | 77.3% |
| Operating income | 15.1 | 9.1 | 12.8 | 18.1 | 17.9 | 11.4 | 13.0 | 6.4 | 9.5 | 9.3 |
| Operating margin | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% | 24.8% | 39.0% | 19.5% | 33.8% | 36.4% |
| Net income | 4.2 | 4.3 | 4.9 | 11.8 | 11.5 | 4.6 | 7.9 | 5.7 | 5.3 | 6.0 |
| Net margin | 6.9% | 7.6% | 9.0% | 20.4% | 20.5% | 10.1% | 23.7% | 17.4% | 18.8% | 23.2% |
| Diluted EPS | $2.36 | $2.40 | $2.73 | $6.61 | $6.45 | $2.86 | $5.28 | $3.58 | $3.29 | $3.63 |
| Free cash flow | 17.8 | 17.8 | 22.1 | 24.2 | 22.0 | 16.8 | 12.8 | 12.8 | 9.4 | 6.6 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ABBV in Markets.
See also: ABBV valuation and P/E history · ABBV returns
No forecast, no recommendation. This page describes AbbVie Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.